SPRINGWORKS THERAPEUTICS, INC. (SWTX) News

SPRINGWORKS THERAPEUTICS, INC. (SWTX): $26.52

1.90 (+7.72%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SWTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 399

in industry

Filter SWTX News Items

SWTX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

SWTX News Highlights

  • For SWTX, its 30 day story count is now at 5.
  • Over the past 23 days, the trend for SWTX's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • CONN, MSCI and NOVA are the most mentioned tickers in articles about SWTX.

Latest SWTX News From Around the Web

Below are the latest news stories about SpringWorks Therapeutics Inc that investors may wish to consider to help them evaluate SWTX as an investment opportunity.

SpringWorks Therapeutics GAAP EPS of -$1.15

SpringWorks Therapeutics press release (SWTX): Q4 GAAP EPS of -$1.15.Cash, cash equivalents and marketable securities were $432.7 million as of December 31, 2021.

Seeking Alpha | February 24, 2022

SpringWorks Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Business Highlights

– Topline Analysis from Phase 3 DeFi Trial Expected to be Triggered in the First Quarter of 2022; Topline Data Expected to be Reported During the First Half of 2022 – – Expanded Collaboration with GlaxoSmithKline to Include Two New Sub-Studies Evaluating the Combination of Nirogacestat Plus BLENREP with Standard-of-Care Multiple Myeloma Therapies; Initial Clinical Data from Ongoing Study Expected Mid-Year – – Further Advanced Broad, Non-Exclusive Strategy to Evaluate Nirogacestat as a Potential

Yahoo | February 24, 2022

8 Medical Stocks to Buy According to Mitchell Blutt’s Consonance Capital

In this article, we will be looking at the 8 medical stocks to buy according to Mitchell Blutt’s Consonance Capital. You can skip our detailed analysis of these stocks and head directly to 3 Medical Stocks to Buy According to Mitchell Blutt’s Consonance Capital. Mitchell Blutt is an American physician-businessman. He is one of the […]

Yahoo | February 15, 2022

CIBC Asset Management Inc Buys Bank of Nova Scotia, Franco-Nevada Corp, Suncor Energy Inc, ...

Toronto, A6, based Investment company CIBC Asset Management Inc (Current Portfolio) buys Bank of Nova Scotia, Franco-Nevada Corp, Suncor Energy Inc, NVIDIA Corp, iShares MSCI EAFE ETF, sells Shaw Communications Inc, Progressive Corp, Visa Inc, Allegion PLC, Lightspeed Commerce Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, CIBC Asset Management Inc.

Yahoo | February 8, 2022

SpringWorks Therapeutics to Present at Upcoming Investor Conferences

STAMFORD, Conn., Feb. 01, 2022 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that management will present at the following upcoming investor conferences: 2022 Guggenheim Oncology Conference on Thursday, February 10 from 10:00-10:25 am ET.Cowen 42nd Annual Health Care Conference on Monday, March 7 from 1:30-2:00 pm ET.Barc

Yahoo | February 1, 2022

SpringWorks Therapeutics, Inc. (SWTX): Hedge Funds Are Snapping Up

Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at […]

Yahoo | January 12, 2022

SpringWorks Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

STAMFORD, Conn., Jan. 04, 2022 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that Saqib Islam, Chief Executive Officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 8:15 am ET. A video webcast will be available on the Events & Presentations page within the Investors & M

Yahoo | January 4, 2022

Fiera Capital Small Mid-cap Growth Fund Buys Devon Energy Corp, Ares Management Corp, Icon ...

Investment company Fiera Capital Small Mid-cap Growth Fund (Current Portfolio) buys Devon Energy Corp, Ares Management Corp, Icon PLC, Hyatt Hotels Corp, Invesco, sells Biomarin Pharmaceutical Inc, Zynga Inc, Landstar System Inc, PVH Corp, Qualys Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Fiera Capital Small Mid-cap Growth Fund .

Yahoo | December 28, 2021

Fiera Capital Corp Buys Devon Energy Corp, Gartner Inc, Ares Management Corp, Sells Rogers ...

Montreal, A8, based Investment company Fiera Capital Corp (Current Portfolio) buys Devon Energy Corp, Gartner Inc, Ares Management Corp, Edwards Lifesciences Corp, Icon PLC, sells Rogers Communications Inc, PVH Corp, Biomarin Pharmaceutical Inc, Landstar System Inc, Zynga Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Fiera Capital Corp.

Yahoo | December 17, 2021

H.C. Wainwright Stick to Their Buy Rating for Springworks Therapeutics By Investing.com

H.C. Wainwright Stick to Their Buy Rating for Springworks Therapeutics

Investing.com | December 15, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4024 seconds.